The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services. 

In his drive to keep China from sprinting ahead of the U.S. in the AI arms race, President Trump may be willing to cut some risky corners.

Physicians expressed concern Monday about newly proposed "efficiency adjustments" in the federal payment program, which could drag down reimbursement for many services. 

The Consumer Financial Protection Bureau joined trade lobby groups in asking a federal court to vacate the rule, which would have forbidden creditors from considering medical debt in lending decisions.

Under the direction of U.S. Attorney General Pam Bondi, charges against Michael Kirk Moore Jr., MD, were dropped just as his trial began. He had been accused of destroying 1,937 doses of COVID-19 vaccines and accepting kickbacks for falsifying vaccine records.

Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.

Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.

In the past year, there has been a record number of new medical AI submissions, resulting in 300 new clinical AI clearances. The number of submissions has been steadily rising over the past decade.